Project Grant R01HL173601

Award Date 5/1/25
Completion Date 4/30/30
Dollars Obligated $703K
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
South Carolina, USA
Similar Awards
This $809,029 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports a randomized controlled trial to evaluate the effectiveness of gamification and social incentives in increasing physical activity adherence among patients with heart failure with preserved ejection fraction (HFPEF). The 5-year study, set to commence on August 1, 2024, aims to: 1) evaluate the impact of gamification plus either...
This Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) totaling $728,781 aims to test the effectiveness and implementation of a home-based exercise intervention for individuals with an implantable cardioverter defibrillator (ICD). The University of Washington is the prime awardee and will collaborate with the University of Colorado-Denver on this 5-year study. The key products and services to be delivered under this grant...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $733,805 to The Regents of the University of California, San Francisco (UCSF) to conduct a 6-month randomized controlled trial. The objective is to test the efficacy of a virtual coaching and social support intervention to improve physical activity, psychosocial, social cognitive, and clinical outcomes for older adults (age 60 and...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a 5-year, $462,012 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Texas A&M University System Health Science Center (TAMU HSC). The objective is to evaluate the feasibility of using Ecological Momentary Assessment (EMA) and Social Network Analysis (SNA) techniques to collect primary data on the associations between social and built environments and physical activity among 100 youth during the...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $374,592 to the University of Rochester to support a research study evaluating the impact of an electronically-delivered rehabilitation program for patients after hospitalization for acute pulmonary embolism. The study, led by Dr. Lachant, aims to investigate whether a prescriptive exercise program with heart rate monitoring can reduce...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $691,299 to the University of California, San Diego (UCSD) to conduct a hybrid type 1 effectiveness-implementation trial of federally qualified health center (FQHC) referrals to a remotely delivered physical activity intervention for Latina adolescents. The intervention, called "Chicas Fuertes 2," uses scalable mobile...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $477,290 to investigate the underlying behavioral mechanisms that contribute to successful and sustainable increases in daily physical activity for COPD patients participating in a home-based pulmonary rehabilitation program. The award aims to determine how patterns of physical activity, sedentary behavior, sleep, cognitive...
This $197,748 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) supports research on low cardiorespiratory fitness and chronotropic incompetence in individuals with HIV. The 5-year project, which began on June 1, 2024, will be conducted by the Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution. The research aims to investigate risk...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $422,894 to Miami University to investigate the interactive roles of cardiorespiratory fitness and adiposity on the recovery of impaired glucose and vascular control following a period of physical inactivity. The key objectives are to 1) examine how existing health status (fitness and adiposity) affects the recovery of impaired...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) provides $789,026 to Beth Israel Deaconess Medical Center, Inc. to evaluate the long-term effectiveness and value of cardiac rehabilitation (CR) in diverse patient populations. The key products and services to be delivered include: Using novel causal inference methods on linked, large-scale datasets to assess the real-world effectiveness of...

This $702,964 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) aims to facilitate the implementation of physical activity screening and referral to community-based programs within a large healthcare system in South Carolina. The project, titled "Exercise is Medicine Greenville" (EIMG), seeks to improve the delivery fidelity and reach of a clinic-to-community physical activity program for patients with chronic diseases. Using a stepped wedge, cluster randomized design, the project will evaluate the impact of implementation facilitation on increasing the number, proportion, and representativeness of patients referred to the 12-week community-based physical activity program. The University of South Carolina is the primary awardee and will collaborate with other academic and healthcare partners to assess patient engagement, program effectiveness, and cost savings related to cardiovascular disease prevention and treatment.

Generated 5/13/25, 4:52 AM